Investor Presentation • Dec 18, 2019
Investor Presentation
Open in ViewerOpens in native device viewer


The Peer tatur (eferences to which on and be eeenet o nature inimation which has seen r may be suppled in writing or realy in connection what are furner enquiries) is porised on the subject in deciling to assist the respient in deciling when it when investigation for reseal of or resting in Irresting in Irane Chemists affiliates (nemaily of the "Company" of "C"). This Pesentain shall of the reason with, any contract or commiment whatseer, and it dosent opport obe omprensive or to ontain all the revised may need more to eallate the Company and in the presentation of deliver in this presentation of deliver on to televed by which our resentation does not constitute an offer a recommendation to o any transaction in say seurlies of its affiliates or ussidiares.
no representation waranty of the by C. andra any nember of the C. Grup or ther respective directions, offices, employes, agents, representatives and realiters and or in eati the accuray completess or stimation onlained in this Pesertained of any assumption of the maimum eten permited by an 1 to Company and it respective director, ency regresentation and a closes arpessy discialin any and all liblity with may and any environment on on investment of rom any use of this Presentation or its contents or otherwise in connection therewith.
no receentation or warrant or resorablems of and novellance should be placed on, any valuations, provinces and index on the in the Presention. In a lease, respents sould oncur the Company and the Company and the infrimation on tanes in the Pesention constitues mestment advisence on opinis or recommentations that may been have not been has of financial shuatin or particular needs of any specific resor in herstor in herstor in herstor in bying Company seusines or evaluating the Company and/or its assets is recommended to seek its own financial and other professional advice.
The Presentation and or writter statements made by C. during is presentation of time of time to time the measing of the United States Pices Litizator Reform Act 1995 and the rever wors sub as "telev", "could", "stould", "phone", "antipat", "nimal", "product" or smiller" (pressions are use, the Company s maing fonadel out forward-obling strems may include, but are not linited to those that discuss strates outsides, existing or new markets, operating efficiencies, or other non-historical matters.
These formand projection are no guartes of the perionance and are subject o a number of soumpions, nany of White are world the Empany sontin, which could results, performance of offer materially from those described in or mplessions. Beause with statements on are been now management's telefis and on infornation courner and the could be mapaced or le subject on and uncertainies, including, un of interior in on including, un of intel to, the sis Pike Factor and elserine in our Annual Report of For the year and in subsequent filings with the lefe in the left in the U.S. Section and Entage Commission (SC). Album the Company belevel in sub forward-looking statements and on newspaper of an quide no assumor will can incentral will can incentral will caniest. Exect as otherns equired by CL discinn any intimation on update or revear any one only as of the cate meet, which speak on the vincer and of new information, four events of circumstances or otherwise. Readers , Isteners and views and uncertainles and to not place under eliance on such information.
Cerain market and in the Pesentation were obtined from internal estinates and sudies, where appropriate, as well as from maker reserver. Soci infornation Subi information Sub rcuse data other from surces celeved o be elater the accuray and sompleienes of such infrimation which is not success who we believe on evelope, which have not been independently verified. We cannot assure that such data is accurate or complete.
houlded in this cresentation and establing directed business, adusted puncting incree, adjusted coprating income ecidding thested businesses, adusted businesses, adusted bus encluding theses, affuster rei income ectuding directed businesse and free cash low designed to oproperent the financel information presented in aconomise with GAP bease management believe the send by interest measures should to considerent to and not suppliements to and not superior of and not species now in accordance with G-4P Peace efect our O an e-K for the third quarter on an ille with TASE and the SEC for a connitiation of the no-GAP friancial measures in class in clisi presentation to the most directly comparable financial measures prepared in accordance with GAAP.
Sales in 2018, with balanced product portfolio

Manufacturing plants in 13 countries worldwide

Employees worldwide, 4,500 in Israel
Leading supplier across most business lines and target markets
Market Cap as of Dec 16, 2019 Traded on TASE since 1992 Traded on NYSE since 2014

Industry leading dividend yield
Investment grade rating & positive outlook (Fitch). Net debt to EBITDA reduced from 2.9 as of 2017 year-end to 1.8 as of Sep. 30, 2019
Second largest public Israeli company in terms of sales





essential ingredients
POTASH
IAS
Market Share – Specialty Phosphates – Europe, NA, and LatAm1

POTASH
IAS


| STERBLI | BYALT | SUFF | |
|---|---|---|---|
| YTD SALES (overall) |
(specialty) | OP. Margin (overall) |







STRONG POSITION

80% PRODUCED FROM



STRONG POSITION

THE DEAD SEA









Market Share – Specialty Phosphates – Europe, NA, and LatAm1

US\$/TONNE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
DAP CFR INDIA4

TSP FOB MOROCCO4









Ion :
Diminishing Arable Land
loaniza

56
Electrification
Growing Population
-Dietary Shifts.
Regulations and Environmental
Circular Economy
Artificial Intelligence
850 granted patents
40 innovation projects with universities & startups within the last 5 years

300 FTEs



| \$ millions | Q3 2019 | Q3 2018 | % change | 1-9/2019 | 1-9/2018 | % change |
|---|---|---|---|---|---|---|
| Sales | 1,325 | 1,371 | (3%) | 4,165 | 4,146 | |
| Sales excluding divested businesses(1) |
1,325 | 1,371 | (3%) | 4,165 | 4,096 | 2% |
| Operating income | 201 | 196 | 3% | ୧୧୫ | 1,353 | (51%) |
| Adjusted operating income | 201 | 200 | 1% | 672 | 539 | 25% |
| Adjusted EBITDA | 307 | 295 | 4% | 997 | 842 | 18% |
| Net income | 130 | 129 | 1% | 427 | 1158 | (63%) |
| Adjusted net income | 130 | 134 | (3%) | 431 | 353 | 22% |
| EPS(2) (Presented in US dollars) | 0.10 | 0.10 | 0.33 | 0.91 | (64%) | |
| Adjusted EPS (Presented in US dollars) | 0.10 | 0.10 | 0.34 | 0.728 | 21% | |
| Operating cash flow | 368 | 196 | 83% | 780 | 396 | 97% |
Adjusted operating income, adjusted EFTDA and operitive inpat of the new FRS stacounting stardard in the annunts of 2 million 185 million 185million 1990-tillen
(1) Excluding contributions from divested businesses of Rovita (divested in Q3 2018)
(1) EPS and atiusted BP and income, respective), chiled by veinted and one of other virany shares outstanding. See reconstition table in the appendiation take in the appen
Adjusted EBITDA
\$ millions

Adjusted operating income excluding divested businesses (1)
Adjusted operating income, adjusted EBTDA and operation of the new FRS & accounting stardard in the annunts of \$2 million and \$10 million and \$10 million and \$10 million aspe
(1) Adjusted operating income and adjusted businesses are non-GAP financial measures. See Appendix to this presentation for reconciliation tables.

Operating cash flow
| USD million | FY 2017 | FY 2018 | Q1 2019¹ | Q2 20191 | Q3 20191 |
|---|---|---|---|---|---|
| Long term loans from banks and others | 872 | 352 | 589 | 654 | 599 |
| Debentures | 1,516 | 1,463 | 1,483 | 1,491 | 1,502 |
| Short term credit from banks and others | 822 | 610 | 638 | 598 | 416 |
| Total financial liabilities | 3,210 | 2,425 | 2,710 | 2,743 | 2,577 |
| Financial assets | (173) | (213) | (183) | (219) | (187) |
| Net financial liabilities | 3,037 | 2,212 | 2,527 | 2,524 | 2,390 |
| EBITDA | 1,059 | 1,164 | 1,263 | 1,307 | 1,319 |
| Net Debt/EBITDA | 2.9 | 1.9 | 2.0 | 1.9 | 1.8 |









Establishing & growing operations in Israel 1920s - 1970s

Consolidating & expanding globally 1970s - 2014



proximity to ports & customers
accumulated over decades
innovation

LEVERAGING TECHNOLOGY AND INDUSTRIAL KNOW HOW TO MEET THE NEEDS OF OUR CUSTOMERS
ADOPTING BEST PRACTICES FOR CORPORATE GOVERNANCE
TOP TIER SAFETY PERFORMANCE AND ENVIROMENTAL RESPONSIBILITY
EMPLOYER OF CHOICE

Enabling a variety of industries to enjoy safer products as well as more efficient and sustainable production

BIOCIDES




Average market utilization rate of 70-80%

Clean Air Mercury Emissions Control
Renewable energy Energy storage
Electric car/ Autonomous car
Home automation
Water shortage and treatment
ICL's Solutions
MERQUEL®

Electrolytes for Bromine Flow battery
New generation polymeric FRs
New generation polymeric FRs
New Biocides




CONCRETING OUR GLOBAL LEADERSHIP OF THE BROMINE MARKET

Increasing Demand via new bromine applications

Advocacy & Regulation

Value over volume

Enhancing complementary business


Without an improvement in crop yields, the demand for food will far outpace production


Source: FAO


31% 16% 13% 23% 15% 2%
Canpotex Uralkali APC BPC ICL K & S

APC BPC Canpotex ICL Uralkali K+S

Canpotex Uralkali SQM BPC ICL K&S

SQM BPC Uralkali K+S Canpotex ICL


Uralkali BPC Canpotex APC ICL K+S Other
38%
4%

19%
Uralkali BPC Canpotex ICL APC Others










ESSENTIAL MINERALS

BITE

TASTE &

MOUTH FEEL TEXTURE & LAST LONGER

RISE



treatment



Growth in production, improving market conditions and efficiency measures resulted in a positive operating income1 in 2018
| \$ million | Q3'19 YTD |
2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|
| Sales | 273 | 387 | 363 | 377 | ||
| 630K TONNES |
Operating income1 |
19 | 9 | (19) | (76) | ▪ |
A leading provider of value added solutions for the industrial, food and agriculture end markets

Increase capacity of purified phosphoric acid, the base raw material for our downstream specialty products & solutions

Value based product positioning

Innovation new applications & solutions

Geographic expansion

Outgrow the market








2B MORE PEOPLE WITHIN 20 YEARS

GROW MORE CHANGE WITH LESS


GROUNDBREAKING SOLUTIONS











| Operating Income | Q1 2017 | Q2 2017 | Q3 2017 | Q4 2017 | FY 2017 | Q1 2018 | Q2 2018 | Q3 2018 | Q4 2018 | FY 2018 | Q1 2019 | Q2 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Industrial Products (Bromine) | |||||||||||||
| Profit before allocated G&A expenses | 77 | 76 | 77 | 73 | 303 | 78 | 94 | 95 | 83 | 350 | 108 | 105 | 99 |
| Allocated G&A expenses (income) | 11 | 17 | 14 | 14 | 56 | 12 | 13 | 12 | 13 | 50 | 11 | 12 | 11 |
| Segment profit | 66 | 59 | 63 | 59 | 247 | 66 | 81 | 83 | 70 | 300 | 97 | 93 | 88 |
| Potash | |||||||||||||
| Profit before allocated G&A expenses | 37 | 61 | 65 | 119 | 282 | 62 | 76 | 97 | 158 | 393 | 98 | 123 | 99 |
| Allocated G&A expenses (income) | 21 | 21 | 21 | 21 | 84 | 19 | 20 | 19 | 20 | 78 | 19 | 18 | 16 |
| Segment profit | 16 | 40 | 44 | 98 | 198 | 43 | 56 | 78 | 138 | 315 | 79 | 105 | 83 |
| Phosphate Solutions | |||||||||||||
| Profit before allocated G&A expenses | 37 | 37 | 52 | 23 | 149 | 52 | 55 | 63 | 38 | 208 | 63 | 58 | 57 |
| Allocated G&A expenses (income) | 26 | 22 | 24 | 24 | 96 | 24 | 24 | 23 | 24 | 95 | 28 | 26 | 25 |
| Segment profit | 11 | 15 | 28 | (1) | 53 | 28 | 31 | 40 | 14 | 113 | 35 | 32 | 32 |
| Innovative Ag Solutions | |||||||||||||
| Profit before allocated G&A expenses | 20 | 19 | 9 8 |
56 | 25 | 23 | 7 | 2 57 |
21 | 21 | 6 | ||
| Allocated G&A expenses (income) | 7 | 6 | 7 7 |
27 | 7 | 7 | 8 | 6 28 |
8 | 9 8 |
|||
| Segment profit | 13 | 13 | 2 1 |
29 | 18 | 16 | (1) | (4) 29 |
13 | 12 | (2) | ||
| Other & elimination | |||||||||||||
| Profit before allocated G&A expenses | 2 - |
(4) | (3) | (5) | (2) | 4 | 2 | (5) | (1) 14 |
(12) | 2 | ||
| Allocated G&A expenses (income) | 1 (1) |
(6) | 4 | (2) | 8 | (2) | 1 | (1) 6 |
(3) - |
2 | |||
| Segment profit | 1 | 1 | 2 (7) |
(3) | (10) | 6 | 1 | (4) | (7) 17 |
(12) | - | ||
| ICL | |||||||||||||
| Total adjusted operating income before G&A expenses | 173 | 193 | 199 | 220 | 785 | 215 | 252 | 264 | 276 1,007 | 304 | 295 | 263 | |
| G&A expenses | 66 | 65 | 60 | 70 | 261 | 70 | 62 | 63 | 62 | 257 | 63 | 65 | 62 |
| Adjusted operating income - excl. divestments | 107 | 128 | 139 | 150 | 524 | 146 | 190 | 200 | 214 | 750 | 241 | 230 | 201 |
| Divested businesses' contribution* | 9 25 |
76 | 18 | 128 | 5 | (2) | - | - | 3 | - | - | - | |
| Adjusted operating income | 116 | 153 | 215 | 168 | 652 | 151 | 188 | 200 | 214 | 753 | 241 | 230 | 201 |

| Calculation of adjusted income before tax (\$ millions) | Q3 19 | Q3 18 | FY2018 | |||
|---|---|---|---|---|---|---|
| Adjusted operating income | 201 | 200 | 753 | |||
| Finance expenses | (32) | (23) | (158) | |||
| Share in earnings (losses) of equity-accounted investees and adjustments to financial expenses | 2 | 13 | ||||
| Adjusted income before tax | 169 | 179 | 608 | |||
| Calculation of adjusted net income excluding divested businesses to net income |
Q3 2019 | Q3 2018 | Q1-Q3 2019 | Q1-Q3 2018 | ||
| Net income attributable to the shareholders of the Company | 130 | 129 | 427 | 1,158 | ||
| Iotal adjustments to operating income | 4 | く | (814) | |||
| Adjustments to finance expenses[1] | 3 | 3 | ||||
| Total tax impact of the above operating income & finance expenses adjustments® | - | (2) | 6 | |||
| Contribution from divested businesses | ||||||
| Total adj. net income excluding divested businesses - shareholders of the Company | 130 | 134 | 431 | 354 | ||
| Weighted-average diluted number of ordinary shares outstanding | 1,283,675 | 1,278,780 | 1,283,401 | 1,276,564 | ||
| Adjusted EPS excluding divested businesses (US dollar) | 0.10 | 0.10 | 0.34 | 0.28 |
| Calculation of adjusted operating income and adjusted operating income excluding divested businesses |
Q1-Q3 2019 | Q1-Q3 2018 | Q1-Q3 2017 | Q1-Q3 2016 | |
|---|---|---|---|---|---|
| Operating income | ୧୧୫ | 1,353 | 440 | (75) | |
| Capital gain | (841) | (6) | 1 | ||
| Impairment loss (reversal) | (10) | 19 | 18 | ||
| Provision for early retirement and dismissal of employees | - | 7 | 26 | ||
| Provision for legal claims | 14 | 1 | 11 | 7 | |
| Provision for electricity charges | - | (18) | |||
| Provision in respect of prior periods resulting from an arbitration decision | 6 | 10 | |||
| Total adjustments(1) | 4 | (814) | 44 | 517 | |
| Divested businesses' profit | (3) | 101 | 73 | ||
| Adjusted operating income excluding divested businesses | 672 | 536 383 |
369 | ||
| Calculation of adjusted EBITDA excluding divested businesses to net income | Q1-Q3 2019 | Q1-Q3 2018 | Q1-Q3 2017 | Q1-Q3 2016 | |
| Net income attributable to the shareholders of the Company | 427 | 1,158 | 209 | (154) | |
| Depreciation and Amortization | 330 | 296 | 286 | 306 | |
| Financing expenses, net | 104 | 92 | 99 | 113 | |
| Taxes on income | 132 | 110 | 145 | 5 | |
| Adjustments(1) | 4 | (814) | 44 | 517 | |
| Contribution from divested businesses | (5) | (109) | (79) | ||
| Adjusted EBITDA excluding divested businesses | 997 | 837 | 674 | 708 |
| Calculation of adjusted operating income and adjusted operating income excluding divested businesses (s millions) |
Q3 19 | Q2 19 | Q1 19 | Q4 18 | Q3 18 | Q2 18 | 01 18 |
|---|---|---|---|---|---|---|---|
| Operating income | 201 | 240 | 227 | 166 | 196 | 172 | 985 |
| Capital gain | (841) | ||||||
| Impairment loss (reversal) | (10) | 3 | 18 | - | |||
| Provision for early retirement and dismissal of employees | 7 | ||||||
| Provision for legal claims | 14 | 30 | 1 | ||||
| Provision for closure costs | 18 | ||||||
| Total adjustments(1) | (10) | 14 | 48 | 4 | 16 | (834) | |
| Adjusted operating income | 201 | 230 | 241 | 214 | 200 | 188 | 151 |
| Divested businesses' profit | 2 | (5) | |||||
| Adjusted operating income excluding divested businesses | 201 | 230 | 241 | 214 | 200 | 190 | 146 |
| Calculation of adjusted EBITDA excluding divested businesses to net income (smillions) | Q3 19 | 02 19 | 01 19 | Q4 18 | Q3 18 | Q2 18 | 01 18 |
| Net income attributable to the shareholders of the Company | 130 | 158 | 139 | 82 | 129 | 101 | 928 |
| Depreciation and Amortization | 110 | 109 | 111 | 107 | 94 | 105 | 97 |
| Financing expenses, net | 32 | 37 | 35 | ୧୧ | 23 | 54 | 15 |
| Taxes on income | 35 | 46 | 51 | 19 | 45 | 20 | 45 |
| Adjustments(1) | (10) | 14 | 48 | 4 | 16 | (834) | |
| Contribution from divested businesses | 2 | (7) | |||||
| Adjusted EBITDA excluding divested businesses | 307 | 340 | 350 | 322 | 295 | 298 | 244 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.